NewCo News: MingSight to Offer 'Bright' Solution for Diabetic Eye Disease
By Marie Powers
Wednesday, June 15, 2011
Using technology acquired from Pfizer Inc., San Diego-based biotech MingSight Pharmaceuticals Inc. has its eye on an oral therapy for retinal diseases.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.